argenx SE (ARGNF)
OTCMKTS
· Delayed Price · Currency is USD
814.94
+20.34 (2.56%)
At close: Feb 12, 2026
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$2,656,692
Profits / Employee
$808,027
Market Cap
44.16B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Nuo Therapeutics | 9 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
| ZIVO Bioscience | 7 |
argenx SE News
- 8 hours ago - Wedbush Reiterates Outperform Rating for argenx (ARGX) with $1000 Price Target | ARGX Stock News - GuruFocus
- 3 days ago - argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline - GlobeNewsWire
- 4 days ago - Oversold Conditions For argenx (ARGX) - Nasdaq
- 4 days ago - Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today - Benzinga
- 6 days ago - Baron Health Care Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 7 days ago - argenx SE at TD Cowen Healthcare Conference Transcript - GuruFocus
- 10 days ago - RBC Capital Lowers Price Target for argenx (ARGX) Amidst Maintained 'Outperform' Rating | ARGX ... - GuruFocus
- 10 days ago - Wells Fargo Lowers Price Target for argenx (ARGX) but Maintains Overweight Rating | ARGX Stock News - GuruFocus